Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1982 1
1984 1
1986 1
1989 1
1993 1
1997 1
2003 1
2006 2
2007 2
2008 3
2009 5
2010 2
2011 3
2012 3
2013 7
2014 5
2016 1
2019 1
2020 1
2022 2
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Oncology Combination Drug Development Strategies for Project Optimus.
Yap TA, Bullock J, Chong S, Doyle MK, Hussain A, Kline J, Manon A, Venkatakrishnan K, Upreti VV. Yap TA, et al. Among authors: doyle mk. Clin Cancer Res. 2024 Dec 2;30(23):5237-5241. doi: 10.1158/1078-0432.CCR-24-1836. Clin Cancer Res. 2024. PMID: 39365679 Review.
Drug-induced vasculitis.
Doyle MK, Cuellar ML. Doyle MK, et al. Expert Opin Drug Saf. 2003 Jul;2(4):401-9. doi: 10.1517/14740338.2.4.401. Expert Opin Drug Saf. 2003. PMID: 12904096 Review.
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.
McInnes IB, Kavanaugh A, Gottlieb AB, Puig L, Rahman P, Ritchlin C, Brodmerkel C, Li S, Wang Y, Mendelsohn AM, Doyle MK; PSUMMIT 1 Study Group. McInnes IB, et al. Among authors: doyle mk. Lancet. 2013 Aug 31;382(9894):780-9. doi: 10.1016/S0140-6736(13)60594-2. Epub 2013 Jun 13. Lancet. 2013. PMID: 23769296 Clinical Trial.
Interferon-induced sarcoidosis.
Doyle MK, Berggren R, Magnus JH. Doyle MK, et al. J Clin Rheumatol. 2006 Oct;12(5):241-8. doi: 10.1097/01.rhu.0000240035.67652.9d. J Clin Rheumatol. 2006. PMID: 17023810 Review.
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Craig T, Magerl M, Levy DS, Reshef A, Lumry WR, Martinez-Saguer I, Jacobs JS, Yang WH, Ritchie B, Aygören-Pürsün E, Keith PK, Busse P, Feuersenger H, Pawaskar D, Jacobs I, Pragst I, Doyle MK. Craig T, et al. Among authors: doyle mk. Lancet. 2022 Mar 5;399(10328):945-955. doi: 10.1016/S0140-6736(21)02225-X. Epub 2022 Feb 24. Lancet. 2022. PMID: 35219377
Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years.
Rahman MU, Buchanan J, Doyle MK, Hsia EC, Gathany T, Parasuraman S, Aletaha D, Matteson EL, Conaghan PG, Keystone E, van der Heijde D, Smolen JS. Rahman MU, et al. Among authors: doyle mk. Ann Rheum Dis. 2011 Sep;70(9):1631-40. doi: 10.1136/ard.2010.146043. Epub 2011 Jun 27. Ann Rheum Dis. 2011. PMID: 21708910 Free PMC article.
Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J. Doyle MK, et al. Semin Arthritis Rheum. 2009 Oct;39(2):123-31. doi: 10.1016/j.semarthrit.2008.08.002. Epub 2008 Sep 27. Semin Arthritis Rheum. 2009. PMID: 18823645 Review.
41 results